secwatch.observer — SEC 8-K summary
======================================

Issuer:     AbCellera Biologics Inc. (ABCL)
CIK:        0001703057
Form:       8-K
Filed at:   2025-06-13T23:59:59+00:00
Accession:  0001628280-25-031219
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

AbCellera shareholders approve director elections, auditor ratification, say-on-pay at June 12 meeting
--------------------------------------------------------------------------------

- Carl L.G. Hansen re-elected as Class II director with 141,233,414 for, 444,265 against, 6,760,498 abstain.
- Michael Hayden re-elected as Class II director with 121,244,143 for, 417,794 against, 26,796,240 abstain.
- Ratification of KPMG as auditor for FY2025 passed: 183,078,982 for, 678,941 against, 241,151 abstain.
- Say-on-pay advisory resolution approved: 131,605,595 for, 16,469,354 against, 363,228 abstain, broker non-votes 35,560,807.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1703057/000162828025031219/0001628280-25-031219-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1703057/000162828025031219/abcl-20250612.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-031219

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer